| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABO blood group is a cardiovascular risk factor in patients with familial hypercholesterolemia
|
Paquette, Martine
|
|
2018
|
12 |
2 |
p. 383-389.e1
|
artikel
|
| 2 |
A case of apolipoprotein A-I deficiency due to carboxyl-terminal truncation
|
Tanaka, Sho
|
|
2018
|
12 |
2 |
p. 511-514
|
artikel
|
| 3 |
A Case of Cerebrotendinous Xanthomatosis
|
Geller, Andrew
|
|
2018
|
12 |
2 |
p. 554
|
artikel
|
| 4 |
A common variant in ARHGEF10 alters delta-6 desaturase activity and influence susceptibility to hypertriglyceridemia
|
de Toro-Martín, Juan
|
|
2018
|
12 |
2 |
p. 311-320.e3
|
artikel
|
| 5 |
A comparison of three apolipoprotein B methods and their associations with incident coronary heart disease risk over a 12-year follow-up period: The Multi-Ethnic Study of Atherosclerosis
|
Cao, Jing
|
|
2018
|
12 |
2 |
p. 300-304
|
artikel
|
| 6 |
Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia
|
Hartgers, Merel L.
|
|
2018
|
12 |
2 |
p. 390-396.e8
|
artikel
|
| 7 |
A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome
|
Paquette, Martine
|
|
2018
|
12 |
2 |
p. 506-510
|
artikel
|
| 8 |
ApoA1 Remnant Ratio in Very High Risk Patients with LDL-c <70mg/dL and Non-HDL-c <100mg/dL: Ramifications for Residual Risk in Women > 55 Years of Age
|
Nelson, John
|
|
2018
|
12 |
2 |
p. 515-516
|
artikel
|
| 9 |
Apolipoprotein A-I: A favorable prognostic marker in infective endocarditis
|
Wei, Xue-biao
|
|
2018
|
12 |
2 |
p. 498-505
|
artikel
|
| 10 |
Apolipoprotein B measurement: Need for standardization
|
Contois, John H.
|
|
2018
|
12 |
2 |
p. 264-265
|
artikel
|
| 11 |
A Preliminary Economic Evaluation of Lipid Screening and Treatment Methods in Youth and Adolescents*
|
Chen, Linda
|
|
2018
|
12 |
2 |
p. 538
|
artikel
|
| 12 |
A Report of Endstage Liver Disease from Coexisting Hypobetalipoproteinemia and Familial Partial Lipodystrophy
|
Subramanian, Savitha
|
|
2018
|
12 |
2 |
p. 518-519
|
artikel
|
| 13 |
Assessing the Disease Burden among Patients with Familial Chylomicronemia Syndrome (FCS) on Volanesorsen: Results of the Re-FOCUS Study
|
Arca, Marcello
|
|
2018
|
12 |
2 |
p. 537-538
|
artikel
|
| 14 |
Assessment of arterial stiffness in patients with familial hypercholesterolemia
|
Tada, Hayato
|
|
2018
|
12 |
2 |
p. 397-402.e2
|
artikel
|
| 15 |
Assessment of Lipid Profile in Patients Referred Via the Primary PCI Pathway. Are We Missing Patients with Familial Hypercholesterolaemia?
|
Elgerray, Samir
|
|
2018
|
12 |
2 |
p. 516-517
|
artikel
|
| 16 |
Association of breastfeeding duration with dyslipidemia in women aged over 20 years: Korea National Health and Nutrition Examination Survey 2010–2014
|
Cho, Sunyoung
|
|
2018
|
12 |
2 |
p. 437-446
|
artikel
|
| 17 |
Associations of lipoproteins with cardiovascular and infection-related outcomes in patients receiving hemodialysis
|
Kaysen, George A.
|
|
2018
|
12 |
2 |
p. 481-487.e14
|
artikel
|
| 18 |
Atherosclerotic Risk Based on Calcium Score in Primary Biliary Cholangitis*
|
Kunkes, Jordan
|
|
2018
|
12 |
2 |
p. 540-542
|
artikel
|
| 19 |
A 10 Year Old Female with Low HDL Cholesterol
|
Hamilton, Luke
|
|
2018
|
12 |
2 |
p. 528
|
artikel
|
| 20 |
Cardiovascular Disease Risk Factor Response to a Type 2 Diabetes Care Model Including Nutritional Ketosis at One Year*
|
McKenzie, Amy
|
|
2018
|
12 |
2 |
p. 521
|
artikel
|
| 21 |
Cardiovascular Risk Assessment: Results from the Framingham Offspring Study
|
Schaefer, Ernst
|
|
2018
|
12 |
2 |
p. 522-523
|
artikel
|
| 22 |
Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy
|
Galema-Boers, Annette M.
|
|
2018
|
12 |
2 |
p. 409-416
|
artikel
|
| 23 |
Case Report: Can a Different PCSK9I be used after Intense Local Reaction to Another PCSK9I?
|
Bramlet, Dean
|
|
2018
|
12 |
2 |
p. 549-550
|
artikel
|
| 24 |
Characterization of Statin Therapy in a Managed Care Population with Diabetes
|
Anderson, Sarah
|
|
2018
|
12 |
2 |
p. 536
|
artikel
|
| 25 |
Chylomicronemia and Pancreatitis
|
Davila, Ashley
|
|
2018
|
12 |
2 |
p. 555
|
artikel
|
| 26 |
Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels—The zero-LDL hypothesis
|
Masana, Luis
|
|
2018
|
12 |
2 |
p. 292-299.e3
|
artikel
|
| 27 |
Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guideline
|
Bucheit, John D.
|
|
2018
|
12 |
2 |
p. 367-374.e3
|
artikel
|
| 28 |
Community Educational Program Decreases Total Cholesterol in 2 weeks*
|
Ramirez, Francisco
|
|
2018
|
12 |
2 |
p. 552
|
artikel
|
| 29 |
Differential Effect of Statin on High-Density Lipoprotein Cholesterol Level in Hypercholesterolemic Patients
|
Kim, Sang-Hyun
|
|
2018
|
12 |
2 |
p. 566-567
|
artikel
|
| 30 |
Differential Responses to the PCSK9 Inhibitors, Evolocumab and Alirocumab, in a Patient with Heterozygous Familial Hypercholesterolemia: A Case Report
|
Doyle, Michael
|
|
2018
|
12 |
2 |
p. 558-559
|
artikel
|
| 31 |
Do Biomarkers Improve Short-term Risk Prediction of Global Cardiovascular Events in Older Adults? Insights from the Atherosclerosis Risk in Communities Study*
|
Saeed, Anum
|
|
2018
|
12 |
2 |
p. 525-526
|
artikel
|
| 32 |
Do Children Who Undergo Treatment with Antipsychotic Medications Receive Adequate Screening of Cardiovascular Disease Risk Factors?
|
Hamilton, Luke
|
|
2018
|
12 |
2 |
p. 535
|
artikel
|
| 33 |
Does Hypercholesterolemia Relates to Higher Levels of Depression? *
|
Nedley, Neil
|
|
2018
|
12 |
2 |
p. 549
|
artikel
|
| 34 |
Dyslipidemia and lipid-lowering treatment in a hematopoietic stem cell transplant cohort: 25 years of follow-up data
|
Premstaller, Melanie
|
|
2018
|
12 |
2 |
p. 464-480.e3
|
artikel
|
| 35 |
Editorial Board
|
|
|
2018
|
12 |
2 |
p. A1-A4
|
artikel
|
| 36 |
Effect of Lipoprotein Apheresis via Liposorber System versus Plasmapheresis on LDL-cholesterol for Two Patients with Familial Hypercholesterolemia*
|
Baddour, Elisa
|
|
2018
|
12 |
2 |
p. 548-549
|
artikel
|
| 37 |
Effect of PCSK9 Inhibitors on Plasma Ceramide Levels *
|
Ye, Qian
|
|
2018
|
12 |
2 |
p. 562
|
artikel
|
| 38 |
Effect of Sebelipase Alfa Administered for 20 Weeks on Serum Lipoprotein Levels In Patients with Lysosomal Acid Lipase Deficiency Having Identical LIPA Mutations versus Multiple LIPA Mutations
|
Maciejko, James
|
|
2018
|
12 |
2 |
p. 548
|
artikel
|
| 39 |
Efficacy of Lomitapide Across the Spectrum of Homozygous Familial Hypercholesterolemia
|
Hegele, Robert
|
|
2018
|
12 |
2 |
p. 560
|
artikel
|
| 40 |
Elevated Lipoprotein (a) Masquerading as Homozygous Familial Hypercholesterolemia*
|
Vani, Anish
|
|
2018
|
12 |
2 |
p. 542
|
artikel
|
| 41 |
Evaluating the Impact of Peer Support and Connection on the Quality of Life of Patients with Familial Chylomicronemia Syndrome
|
Salvatore, Valerie
|
|
2018
|
12 |
2 |
p. 538-539
|
artikel
|
| 42 |
Examing the High Disease Burden and Impact on Quality of Life in Familial Chylomicronemia Syndrome †
|
Davidson, Michael
|
|
2018
|
12 |
2 |
p. 536-537
|
artikel
|
| 43 |
Factors Influencing Statin use in Patients Medically Managed for Chronic Hepatitis C Virus (HCV) in an Urban Healthcare System*
|
Patel, Ammie
|
|
2018
|
12 |
2 |
p. 547-548
|
artikel
|
| 44 |
Familial Chylomicronemia and Population Prevalence of Marked Hypertriglyceridemia
|
Chyzhyk, Vadzim
|
|
2018
|
12 |
2 |
p. 554-555
|
artikel
|
| 45 |
Familial Hypercholesteremia: When Statins, Ezetimibe & PCSK9 Inhibitors Are Not Enough
|
Verma, Isha
|
|
2018
|
12 |
2 |
p. 545
|
artikel
|
| 46 |
Familial Hypercholesterolemia Screening Practices Across Mayo Subspecialties
|
Fernandes, Regis
|
|
2018
|
12 |
2 |
p. 539-540
|
artikel
|
| 47 |
Finding Familial Hypercholesterolemia in African American Women at a Community Cardiovascular Screening Event∧
|
Lundberg, Gina
|
|
2018
|
12 |
2 |
p. 546
|
artikel
|
| 48 |
From the editor: Weighing the advantages of lipid conference and journal
|
Guyton, John R.
|
|
2018
|
12 |
2 |
p. 251-252
|
artikel
|
| 49 |
Genetic Testing for Familial Hypercholesterolemia
|
Castro, Andy
|
|
2018
|
12 |
2 |
p. 526-527
|
artikel
|
| 50 |
High frequency of type 2 diabetes and impaired glucose tolerance in Japanese subjects with the angiopoietin-like protein 8 R59W variant
|
Liu, Jianhui
|
|
2018
|
12 |
2 |
p. 331-337
|
artikel
|
| 51 |
High Triglycerides and ASCVD Are Significant Predictors of Major CV Events and Increased Costs in Statin-Treated Patients: Real-World Analysis
|
Toth, Peter
|
|
2018
|
12 |
2 |
p. 528-529
|
artikel
|
| 52 |
Hospital Readmissions for an Acute Cardiac Event After Hospitalization for Atherosclerotic Cardiovascular Disease
|
Boatman, Brian
|
|
2018
|
12 |
2 |
p. 522
|
artikel
|
| 53 |
Human Atherosclerotic Carotid Artery Plaques with Cholesterol Crystals Enhance Bacterial Growth: Risk for Plaque Destabilization*
|
Boumegouas, Manel
|
|
2018
|
12 |
2 |
p. 556-557
|
artikel
|
| 54 |
Hypertriglyceride-Induced Pancreatitis Study (HIPS)
|
Friedrich, Debra
|
|
2018
|
12 |
2 |
p. 530
|
artikel
|
| 55 |
Identifying Risk Factors of Atherosclerotic Cardiovascular Disease in the South Asian Population
|
Elkins, Casey
|
|
2018
|
12 |
2 |
p. 543-544
|
artikel
|
| 56 |
Impact of Clinical Pharmacy Managed Service on PCSK9 Inhibitior Use
|
Dajani, Khaled
|
|
2018
|
12 |
2 |
p. 535
|
artikel
|
| 57 |
Impact of the 2013 ACC/AHA Cholesterol Treatment Guidelines on Cholesterol Management Goals for Secondary Prevention*
|
Yu, Stephanie
|
|
2018
|
12 |
2 |
p. 533-535
|
artikel
|
| 58 |
Increments in serum high-density lipoprotein cholesterol over time are not associated with improved outcomes in incident hemodialysis patients
|
Chang, Tae Ik
|
|
2018
|
12 |
2 |
p. 488-497
|
artikel
|
| 59 |
Injection Site Reactions to PCSK9i Monoclonal Antibody Therapies are caused by Polysorbates in the Products
|
Stark, Craig
|
|
2018
|
12 |
2 |
p. 562-564
|
artikel
|
| 60 |
Insulin Resistance Across the Triglyceride Continuum; Even Further than Expected?
|
Nelson, John
|
|
2018
|
12 |
2 |
p. 517-518
|
artikel
|
| 61 |
Interleukin-1 genotypes modulate the long-term effect of lipoprotein(a) on cardiovascular events: The Ioannina Study
|
Naka, Katerina K.
|
|
2018
|
12 |
2 |
p. 338-347
|
artikel
|
| 62 |
In Vitro Model to Study Chylomicron†
|
Nauli, Andromeda
|
|
2018
|
12 |
2 |
p. 568-569
|
artikel
|
| 63 |
Knowledge, Perceptions, and Patterns of Fish Oil “Use in Cardiac Patients" †
|
Hilleman, Daniel
|
|
2018
|
12 |
2 |
p. 552-553
|
artikel
|
| 64 |
LDL-C Therapeutic Target Attainment in Patients with Homozygous Familial Hypercholesterolemia treated with Lomitapide
|
Underberg, James
|
|
2018
|
12 |
2 |
p. 561-562
|
artikel
|
| 65 |
Lipoprotein X in Graft versus Host Disease of the Liver*
|
Gopal, Dipika
|
|
2018
|
12 |
2 |
p. 542-543
|
artikel
|
| 66 |
Long-term efficacy and safety of proprotein convertase subtilisin/kexin 9 monoclonal antibodies: A meta-analysis of 11 randomized controlled trials
|
Bai, Jie
|
|
2018
|
12 |
2 |
p. 277-291.e3
|
artikel
|
| 67 |
Long-Term Liver Safety of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia: Three-Year Data from LOWER †
|
Larrey, Dominique
|
|
2018
|
12 |
2 |
p. 557-558
|
artikel
|
| 68 |
Long-Term Safety and Efficacy of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia: Three-Year Data from LOWER †
|
Underberg, James
|
|
2018
|
12 |
2 |
p. 559-560
|
artikel
|
| 69 |
Low Density Lipoprotein Triglyceride and Incident Cardiovascular: Insights from the Atherosclerosis Risk in Communities Study*
|
Saeed, Anum
|
|
2018
|
12 |
2 |
p. 527-528
|
artikel
|
| 70 |
Low Vitamin D, but not Creatine Supplementation, Alters the Creatine Kinase Response to Eccentric Exercise in Healthy Adults on Atorvastatin
|
Taylor, Beth
|
|
2018
|
12 |
2 |
p. 550-551
|
artikel
|
| 71 |
LTP Prodrug Technology Offers Opportunity of New Generation Lipid Lowering Agents
|
Zhi, Lin
|
|
2018
|
12 |
2 |
p. 564-565
|
artikel
|
| 72 |
Management of Dyslipidemia: Virtual Simulation Improves Clinical Decision-Making
|
Spyropoulos, Jelena
|
|
2018
|
12 |
2 |
p. 532-533
|
artikel
|
| 73 |
Martin/Hopkins Estimation, Friedewald and Beta-Quantification of LDL-C in Patients in FOURIER*
|
Martin, Seth
|
|
2018
|
12 |
2 |
p. 565-566
|
artikel
|
| 74 |
Maternal lipid profile 6 years after a gestational hypertensive disorder
|
Benschop, Laura
|
|
2018
|
12 |
2 |
p. 428-436.e4
|
artikel
|
| 75 |
News from the NLA
|
|
|
2018
|
12 |
2 |
p. 253
|
artikel
|
| 76 |
Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial
|
Stroes, Erik S.G.
|
|
2018
|
12 |
2 |
p. 321-330
|
artikel
|
| 77 |
Plant Based Diet and Lifestyle Changes Improve Health Markers of Diabetics*
|
Ramirez, Francisco
|
|
2018
|
12 |
2 |
p. 522
|
artikel
|
| 78 |
Plasma EPA(Eicosapentaenoic Acid)/AA (Arachidonic Acid) Ratio in Patients With Stage 5 Chronic Kidney Disease: A Novel, Treatable Target?
|
Nelson, John
|
|
2018
|
12 |
2 |
p. 553-554
|
artikel
|
| 79 |
Pompe Disease Masquerading as Statin Induced Myopathy
|
Milyani, Raneem
|
|
2018
|
12 |
2 |
p. 555-556
|
artikel
|
| 80 |
Prevalence and Predictors of Residual Hypertriglyceridemia According to Statin Use in US Adults*
|
Fan, Wenjun
|
|
2018
|
12 |
2 |
p. 530-531
|
artikel
|
| 81 |
Prevalence of Cardiovascular Risk Factors among Patients Presenting with Premature Myocardial Infarction in the Middle East
|
Dugani, Sagar
|
|
2018
|
12 |
2 |
p. 523-525
|
artikel
|
| 82 |
Prevalence of Diabetes and Statin Treatment in Youth
|
Pineda, Elmor
|
|
2018
|
12 |
2 |
p. 519-521
|
artikel
|
| 83 |
Prevalence of Familial Chylomicronemia Syndrome (FCS): Are We Underestimating?
|
Khavandi, Maryam
|
|
2018
|
12 |
2 |
p. 529-530
|
artikel
|
| 84 |
Prevalence of high cholesterol levels suggestive of familial hypercholesterolemia in Brazilian adolescents: Data from the study of cardiovascular risk in adolescents
|
Kaestner, Tatiana L.
|
|
2018
|
12 |
2 |
p. 403-408
|
artikel
|
| 85 |
Prevalence, patterns, and associations of dyslipidemia among Sri Lankan adults—Sri Lanka Diabetes and Cardiovascular Study in 2005–2006
|
Katulanda, Prasad
|
|
2018
|
12 |
2 |
p. 447-454
|
artikel
|
| 86 |
Relationship Between Dyslipidemia and Short Stature in Adults; from the Korean NHANES Survey
|
Park, Mi-Jung
|
|
2018
|
12 |
2 |
p. 523
|
artikel
|
| 87 |
Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial
|
Otvos, James D.
|
|
2018
|
12 |
2 |
p. 348-355.e2
|
artikel
|
| 88 |
Roundtable discussion: Familial chylomicronemia syndrome: Diagnosis and management
|
Brown, William Virgil
|
|
2018
|
12 |
2 |
p. 254-263
|
artikel
|
| 89 |
Saturated fatty acids and mortality in patients referred for coronary angiography—The Ludwigshafen Risk and Cardiovascular Health study
|
Kleber, Marcus E.
|
|
2018
|
12 |
2 |
p. 455-463.e3
|
artikel
|
| 90 |
Self-reported Lifestyle Behaviors in Younger versus Older Patients with Newly Diagnosed Cardiovascular Disease*
|
Garshick, Michael
|
|
2018
|
12 |
2 |
p. 525
|
artikel
|
| 91 |
Short-Term Impact of Physiological Repletion of Estradiol and Progesterone on LDL-C, HDL-C, nonHDL-C, TC, TG, apo B and Lp(a) Concentrations in Postmenopausal Women
|
Veldhuis, Johannes
|
|
2018
|
12 |
2 |
p. 558
|
artikel
|
| 92 |
Statin Use is Associated with Lower Trimethylamine-N-oxide (TMAO) Level in Adults at Risk of Atherosclerotic Cardiovascular Disease, Independent of Serum Cholesterol and Renal Function. *
|
Milks, Michael
|
|
2018
|
12 |
2 |
p. 567-568
|
artikel
|
| 93 |
Supravalvular Aortic Stenosis in a Patient with Lysosomal Acid Lipase Deficiency
|
Anne, Premchand
|
|
2018
|
12 |
2 |
p. 546-547
|
artikel
|
| 94 |
Synergism between PCSK9 Inhibition and Mipomersen to Lower LDL-C in HOFH
|
Trippi, James
|
|
2018
|
12 |
2 |
p. 540
|
artikel
|
| 95 |
Table of Contents
|
|
|
2018
|
12 |
2 |
p. A5-A8
|
artikel
|
| 96 |
Tailoring Statin Therapy to Reduce The Risk of New-Onset Diabetes: Success of Online CME
|
Spyropoulos, Jelena
|
|
2018
|
12 |
2 |
p. 533
|
artikel
|
| 97 |
The Diagnosis and Treatment of Cerebrotendinous Xanthomatosis
|
Salen, Gerald
|
|
2018
|
12 |
2 |
p. 545-546
|
artikel
|
| 98 |
The Effect of Dairy Consumption on Lipid Profile: A Meta-analysis of Randomized Controlled Trials†
|
Mitri, Joanna
|
|
2018
|
12 |
2 |
p. 551-552
|
artikel
|
| 99 |
The prevalence and etiology of extreme hypertriglyceridemia in children: Data from a tertiary children's hospital
|
Patni, Nivedita
|
|
2018
|
12 |
2 |
p. 305-310
|
artikel
|
| 100 |
Three Week NEWSTART Intervention Improve Laboratories of Patients*
|
Ramirez, Francisco
|
|
2018
|
12 |
2 |
p. 517
|
artikel
|
| 101 |
Treatment Effects of Different Lipid Lowering Regimens on Remnant Cholesterol
|
Isquith, Daniel
|
|
2018
|
12 |
2 |
p. 567
|
artikel
|
| 102 |
Treatment goal attainment in children with familial hypercholesterolemia: A cohort study of 302 children in Norway
|
Bogsrud, Martin P.
|
|
2018
|
12 |
2 |
p. 375-382
|
artikel
|
| 103 |
Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals
|
Zhang, Peiwen
|
|
2018
|
12 |
2 |
p. 417-427.e5
|
artikel
|
| 104 |
Treatment with Volanesorsen (VLN) Reduced Triglycerides and Pancreatitis in Patients with FCS and sHTG vs Placebo: Results of the APPROACH and COMPASS †
|
Gelrud, Andres
|
|
2018
|
12 |
2 |
p. 537
|
artikel
|
| 105 |
Underlying Causes and Management of Patients with Triglycerides > 2000 mg/dL †
|
Ahmad, Zahid
|
|
2018
|
12 |
2 |
p. 531-532
|
artikel
|
| 106 |
Visit-to-visit lipid variability: Clinical significance, effects of lipid-lowering treatment, and (pharmaco) genetics
|
Smit, Roelof A.J.
|
|
2018
|
12 |
2 |
p. 266-276.e3
|
artikel
|
| 107 |
Visit-to-visit variability of lipid measurements as predictors of cardiovascular events
|
Waters, David D.
|
|
2018
|
12 |
2 |
p. 356-366
|
artikel
|
| 108 |
When a Target LDL-C Goal of Less Than 70mg/dl is Not Enough
|
Verma, Isha
|
|
2018
|
12 |
2 |
p. 544-545
|
artikel
|
Tijdschrift beschrijving